In the third activity of this CME Outfitters Snack series, expert faculty will incorporate clinical trial evidence supporting the use of GLP-1 RAs in T2D management, including outcomes related to glucose control, CV safety, CKD, and tolerability. Faculty will model utilization of current treatment guidelines to implement GLP-1 RA therapy tailored to individual patient characteristics, including comorbidities, goals of care, and lifestyle considerations.
In the first activity of this CME Outfitters Snack series, expert faculty will identify the multifaceted impact of GLP-1 RA therapies on glycemic control, CV health, weight management, renal health, liver health, and overall T2D complication risk.
In this CME Outfitters Snack, expert faculty and a patient advocate will discuss clinical experience, study information, updates to guidelines, resources, and how to integrate sensitive and respectful discussions about anal cancer risk, prevention, and screening into everyday clinical workflows to improve outcomes for patients at high risk for anal cancer.
In this CME Outfitters live Q&A, expert faculty will answer questions about the multifaceted impact of GLP-1 RA therapies on glycemic control, CV health, weight management, renal health, liver health, and overall T2D complication risk.
This activity, presented by experts in cardiology, neurology, and advanced practice care, will better equip clinicians to implement best practices in diagnosis, therapeutic strategy, and MDT collaboration to improve clinical outcomes for patients with ATTRv.
In this CME Outfitters Snack, expert faculty, including OB/GYNs, will address the educational needs of providers who care for patients with or at risk for HIV, explaining how to discuss HIV risk with patients and the latest guideline-based care and recommendations for those with or at risk of HIV considering pregnancy or who are currently pregnant.
